Moreover, five of the twelve TFs have been reported to be prognostic biomarkers in specific cancers, such as MAZ, KLF6 and BRF2 in breast cancer8, 29, 30, and ERG1 in colorectal cancer31. The gene discussed is MAZ; the disease is cancer.